2008
DOI: 10.2353/ajpath.2008.080556
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Heme Oxygenase-1 is a Beneficial Response in a Murine Model of Venous Thrombosis

Abstract: ؊/؊ mice exhibited increased nuclear factor B activation and markedly increased up-regulation of tissue factor, selectins, inflammatory cytokines, and matrix metalloproteinase-9, the latter incriminated in both clot lysis and vascular injury. We conclude that HO-1 deficiency impairs thrombus resolution and exaggerates the inflammatory response to thrombus formation. These findings offer insight into recent observations that polymorphisms in the HO-1 gene may increase the risk for recurrent venous thrombosis an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
40
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(41 citation statements)
references
References 48 publications
1
40
0
Order By: Relevance
“…Additionally, the products of the degradation of heme, ionic iron, CO and biliverdin, or their immediate downstream products also contribute to an anti-oxidative, anti-inflammatory state and have anti-thrombotic activity [12,24,25]. DNA polymorphisms which impair or reduce HO-1 response may therefore lead to increased risk of endothelial dysfunction and vascular disease, including resolution of venous thrombosis [14]. Human patients with shorter HMOX1 promoter (GT) n repeat alleles might benefit by having a stronger inducible heme oxygenase response [15,26], and indeed, long alleles were associated with increased risk of recurrent VTE in the only other study to date to examine the role of this polymorphism in VTE [16].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, the products of the degradation of heme, ionic iron, CO and biliverdin, or their immediate downstream products also contribute to an anti-oxidative, anti-inflammatory state and have anti-thrombotic activity [12,24,25]. DNA polymorphisms which impair or reduce HO-1 response may therefore lead to increased risk of endothelial dysfunction and vascular disease, including resolution of venous thrombosis [14]. Human patients with shorter HMOX1 promoter (GT) n repeat alleles might benefit by having a stronger inducible heme oxygenase response [15,26], and indeed, long alleles were associated with increased risk of recurrent VTE in the only other study to date to examine the role of this polymorphism in VTE [16].…”
Section: Discussionmentioning
confidence: 99%
“…Knockout mice which do not express HO-1 have been shown to have an enhanced inflammatory response and significantly impaired resolution of experimentally induced venous thrombosis [14]. Humans carry a (GT) n microsatellite (rs3074372) located in the promoter of the heme oxygenase-1 (HMOX1) gene that may influence the level of HO-1 response whereby individuals with lower numbers of repeats have higher inducible expression [15].…”
Section: Introductionmentioning
confidence: 99%
“…[23][24][25] The nuclear extract (5 g) from five femoral veins of shamoperated rats or three venous limbs of AVFs were pooled for each binding reaction. A double-stranded consensus oligonucleotide for nuclear factor (NF)-B or activator protein (AP)-1 (catalog nos.…”
Section: Electrophoretic Mobility Shift Assay For Analysis Of Nuclearmentioning
confidence: 99%
“…The resulting cDNA was used in quantitative real-time PCR analysis as in our earlier studies. [23][24][25] Reactions were performed on an ABI Prism 7900HT (Applied Biosystems, Foster City, CA) using TaqMan Mastermix reagents (part no. 4309169, Applied Biosystems).…”
Section: Mrna Expression By Quantitative Real-time Reverse Transcriptmentioning
confidence: 99%
See 1 more Smart Citation